U.S. Residential REITs Stock News

Berkshire Hathaway (NYSE:BRK.B) reported Q2 2026 results that included a clear shift in capital allocation under new CEO Greg Abel. The company executed significant share buybacks in Q2 2026, marking its largest quarterly repurchase since 2021. Berkshire initiated a sizable new equity position in Alphabet and returned to being a net buyer of stocks using part of its large cash balance. This renewed appetite for deploying cash into equities points to a broader theme of capital return and...

MannKind (MNKD) recently drew investor attention after reporting positive topline Phase 1b INFLO-1 data for its inhaled nintedanib therapy in idiopathic pulmonary fibrosis patients, highlighting safety, tolerability, and effective deep lung delivery. See our latest analysis for MannKind. The INFLO-1 update has come alongside a sharp move in MannKind’s stock, with a 1-day share price return of 5.66% and a 90-day share price return of 25.30%. However, the year-to-date share price return is down...

SLB has more than doubled investors' money over the past five years, yet its current share price near US$50.53 still sits well below an intrinsic value estimate from a Discounted Cash Flow (DCF) model that points to a 43.6% discount. With that backdrop, recent headlines around offshore stimulation work with Equinor and AI driven drilling operations with ADNOC are being weighed against a reported profit decline linked to disruptions in the Middle East. SLB has returned 103.0% over 5 years,...

Oil prices are in the headlines again as Iran links reopening the Strait of Hormuz to US concessions, and that ripples straight through inflation expectations, interest rate worries, and energy sector stocks. For investors, these kinds of shocks can reshuffle winners and laggards quickly. This article walks through how this backdrop connects to three large cap energy stocks in our screener that appear positively exposed to the latest Hormuz story. The stocks in the article below are just a...

Aflac earnings, dividend and buyback update Aflac (AFL) is back in focus after reporting second quarter 2026 results, declaring a third quarter dividend of $0.61 per share, and updating investors on progress under its long running share repurchase program. See our latest analysis for Aflac. Aflac's recent earnings, dividend affirmation and ongoing buybacks come after a period where the share price has risen 13.04% year to date and the 1 year total shareholder return is 22.17%, building on a 5...

With the U.S. unemployment rate sitting at 4.1% and inflation still above the Fed’s 2% target, investors are watching how longer lasting tight monetary policy could ripple through everything from paychecks to pantry staples. That mix can reshape which consumer stocks feel pressure and which hold up. This article breaks down three large consumer staples stocks exposed to these trends and why they may deserve a closer look now. The three stocks highlighted below are just a sample. The full...

In August 2026, Corebridge Financial, Inc. declared a US$0.25 per-share common dividend, completed a US$5.96 billion share repurchase program after buying back an additional US$300 million in stock, and reported second-quarter 2026 results showing revenue of US$3,914 million and net income of US$2 million compared with a net loss a year earlier. Alongside the earnings improvement, Corebridge expanded its Power Series of Index Annuities with the Protected Growth Benefit and preset allocation...

Pulse Biosciences (PLSE) is back in focus after reporting a wider quarterly net loss and filing a US$75 million at the market equity offering, as its NANOPULSE-AF Study passes the enrollment midpoint. See our latest analysis for Pulse Biosciences. The recent NANOPULSE-AF Study milestone and the US$75 million at the market offering come after a powerful run in Pulse Biosciences' stock, with a 30 day share price return of 61.32% and year to date share price return of 216.73%. The 3 year total...

AnaptysBio (ANAB) has drawn investor attention after recent share price moves, with the stock last closing at US$56.61. The company focuses on immunology therapeutics for autoimmune and inflammatory diseases. See our latest analysis for AnaptysBio. Recent trading has been choppy. The stock has a 1-day share price return of 3.36% and 7-day share price return of 5.50%. However, it is down 14.73% over 30 days, while the year-to-date share price return is 25.94% and the 1-year total shareholder...

Amerant Bancorp (AMTB) recently appointed Yecimar Tirado Camacho as Executive Vice President and Chief Risk Officer. This leadership shift draws fresh attention to how the bank manages risk and how the stock is currently valued. See our latest analysis for Amerant Bancorp. Amerant Bancorp shares now trade at US$28.91, with the 30 day share price return of 13.37% and year to date share price return of 46.68% pointing to building momentum. The 1 year total shareholder return of 54.27% shows...

AeroVironment (AVAV) has attracted fresh investor attention after a reported US$400 million U.S. Army production contract for its Locust directed energy counter drone system, alongside meaningful boardroom changes. See our latest analysis for AeroVironment. AeroVironment’s shares recently moved sharply higher, with a 1-day share price return of 9.12% and 30-day share price return of 29.15%. However, the year-to-date share price return is down 27.11% and the 1-year total shareholder return is...

National HealthCare Corporation recently reported past second-quarter 2026 results showing revenue of US$408.03 million and net income of US$40.32 million, alongside a declared quarterly dividend of US$0.67 per share payable in October 2026. The sharp improvement in earnings per share from continuing operations compared with a year earlier highlights stronger profitability across both the quarterly and six-month reporting periods. Next, we’ll examine how this stronger earnings performance...

Somnigroup International has delivered a 56.6% gain over the past 5 years, yet its current checks point to a mixed valuation picture, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the stock may still trade below its underlying worth, while market multiples look closer to fair. Over the last 5 years Somnigroup International shares are up 56.6%, which indicates shareholders with a longer horizon have seen solid compounding despite more recent weakness. The...

United Community Banks stock has returned 35.0% over the past three years, while the current checks suggest a mixed picture on value and an intrinsic value estimate that sits materially above the recent market price. With the shares last closing at US$35.51, the Excess Returns model indicates the stock trades at a meaningful discount to its assessed intrinsic value, even as earnings-based multiples look broadly in line with peers. Over the past three years United Community Banks has...

Huntington Ingalls Industries (HII) has drawn fresh investor attention after signing long term, performance based production agreements with GrayMatter Robotics and Path Robotics to expand physical AI automation across U.S. Navy shipbuilding programs. See our latest analysis for Huntington Ingalls Industries. These automation agreements come after a busy few weeks for Huntington Ingalls Industries, with the stock at $324.48 and a 30 day share price return of 13.42% helping to offset a year to...

Sabine Royalty Trust recently reported past August 2026 production results showing oil volumes of 72,119 bbls versus 54,139 bbls in the prior month and gas volumes of 1,408,574 Mcf versus 1,074,976 Mcf, alongside a higher cash distribution of US$0.619430 per unit payable on August 31, 2026. This combination of stronger recent oil and gas output and a raised distribution highlights how current asset performance is supporting higher cash payouts. We’ll now examine how the increased cash...

AGNT, Inc ( NASDAQ:AGNT ) stock is about to trade ex-dividend in three days. The ex-dividend date is one business day...

Super Micro Computer (NasdaqGS:SMCI), AMD and Spectro Cloud announced AMD Instinct Coder, an enterprise AI inference solution for private AI deployments. The jointly developed offering combines validated hardware and software to replace piecemeal AI infrastructure projects with a single integrated stack. AMD Instinct Coder is designed for hybrid use across on premises and cloud environments, with policy driven model routing for different workloads. The launch positions Super Micro Computer...

Bending Spoons (BSP) stock is drawing fresh attention after the company opened its third European office in Madrid, expanding its physical presence and recruitment reach across key technology hubs. See our latest analysis for Bending Spoons. Alongside the Madrid opening and the recent €1,490 million financing package, Bending Spoons has seen the share price at $44.45 after a 35.07% 30 day share price return and a 9.75% year to date share price return, suggesting momentum has recently picked...

Service Properties Trust recently reported its second-quarter 2026 results, with revenue falling to US$420.97 million from US$503.44 million a year earlier and net loss widening to US$223.84 million from US$38.16 million. Although the six-month net loss increased to US$375.02 million, basic loss per share from continuing operations was largely unchanged at US$4.63 versus US$4.67 a year earlier, suggesting the larger loss is being spread across a bigger share base. We’ll now examine how this...

In July 2026, QuantumScape reported Q2 results and updated the milestone structure of its PowerCo collaboration, which is intended to support the development and validation of battery cells over the following two years.

CACI International (CACI) is back in focus after reporting record fiscal 2026 revenue, EBITDA margin, and free cash flow, along with fiscal 2027 guidance that points to continued double-digit revenue growth and strong cash generation. See our latest analysis for CACI International. CACI International's recent earnings release and contract wins appear to have shifted sentiment, with a 7 day share price return of 25.7% and a 30 day share price return of 32.5% pointing to strong near term...

HealthEquity stock has delivered a 61.0% return over the past 5 years, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to meaningful upside while earnings based multiples suggest the shares screen as expensive. Over the past 5 years, HealthEquity has returned 61.0%, which puts more focus on whether the current price still offers a margin of safety. Expectations around HealthEquity's ability to convert its revenue base...

Earlier this month, Replimune Group announced that the FDA granted accelerated approval for TUDRIQEV (vusolimogene oderparepvec-wtpg) in combination with nivolumab to treat adults with unresectable advanced cutaneous melanoma that has progressed after anti-PD-1 antibody-based therapy. This decision brings the first approved oncolytic HSV-1 viral therapy for this difficult-to-treat melanoma setting into clinical practice, anchored on objective response rate and duration of response from the...